Logo image
Development status and future prospects for a vaccine against Chlamydia trachomatis infection
Journal article   Open access   Peer reviewed

Development status and future prospects for a vaccine against Chlamydia trachomatis infection

L M Hafner, D P Wilson and Peter Timms
Vaccine, Vol.32(14), pp.1563-1571
2014
pdf
PDF - Author's Accepted Version (Open Access)658.94 kBDownloadView
Accepted VersionPDF - Author Accepted Version (Open Access)CC BY-NC-ND V4.0 Open Access
url
https://doi.org/10.1016/j.vaccine.2013.08.020View
Published Version

Abstract

Biological Sciences Agricultural and Veterinary Sciences Medical and Health Sciences Chlamydia vaccines WHO special issue
Chlamydia trachomatis continues to be the most commonly reported sexually transmitted bacterial infec-tion in many countries with more than 100 million new cases estimated annually. These acute infectionstranslate into significant downstream health care costs, particularly for women, where complicationscan include pelvic inflammatory disease and other disease sequelae such as tubal factor infertility.Despite years of research, the immunological mechanisms responsible for protective immunity versusimmunopathology are still not well understood, although it is widely accepted that T cell driven IFN-gand Th17 responses are critical for clearing infection. While antibodies are able to neutralize infectionsin vitro, alone they are not protective, indicating that any successful vaccine will need to elicit botharms of the immune response. In recent years, there has been an expansion in the number and types ofantigens that have been evaluated as vaccines, and combined with the new array of mucosal adjuvants,this aspect of chlamydial vaccinology is showing promise. Most recently, the opportunities to developsuccessful vaccines have been given a significant boost with the development of a genetic transformationsystem for Chlamydia, as well as the identification of the key role of the chlamydial plasmid in virulence.While still remaining a major challenge, the development of a successful C. trachomatis vaccine is startingto look more likely.

Details

Metrics

13 File views/ downloads
812 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Immunology
Medicine, Research & Experimental

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image